Publications scientifiques Bordet

Publications scientifiques Bordet

  • Randomised trial of trastuzumab deruxtecan and biology-driven selection of neoadjuvant treatment for HER2-positive breast cancer: a study protocol of ARIADNE.

  • Auteurs Matikas A, Naume B, Wildiers H, Sonke G, Dieci MV, Karakatsanis A, Andersson A, Barnekow E, Kessler LE, Einbeigi Z, Killander F, Linderholm B, Schiza A, Valachis A, Nearchou A, Engebraaten O, Porojnicu A, Soland MH, Mannsåker B, Raj SX, Blix ES, Nordstrand CS, Lambertini M, Vernieri C, Punie K, Sotiriou C, Bergh J, Villacampa G, Zouzos A, Hellström M, Hartman J, Foukakis T
  • Revue BMJ Open
  • Date de publication 2025-08
Randomised trial of trastuzumab deruxtecan and biology-driven selection of neoadjuvant treatment for HER2-positive breast cancer: a study protocol of ARIADNE.
  • Brain imaging screening in metastatic breast cancer: patients' and physicians' perspectives.

  • Auteurs Matos L, van Ramshorst M, Müller V, Agostinetto E, Linn S, Lambertini M, Dieras V, le Du F, Braga S, Criscitiello C, Jerzak KJ, Morgan G, Brucker S, von Kroge P, Haidinger R, Rodríguez Recio G, Schumacher-Wulf E, Fontes Sousa M, Schettini F, Laakmann E
  • Revue Breast
  • Date de publication 2025-08
Brain imaging screening in metastatic breast cancer: patients' and physicians' perspectives.
  • Corrigendum to \"Histopathological Insights into Metastatic Breast Cancer Gained From Rapid Autopsies\" [Laboratory Investigation 105(2025) 104202].

  • Auteurs Zels G, Pabba A, De Schepper M, Geukens T, Van Baelen K, Maetens M, Mahdami A, Leduc S, Isnaldi E, Nguyen HL, Bachir I, Van Cauwenberge J, Borremans K, Weynand B, Biganzoli E, Neven P, Wildiers H, Van Den Bogaert W, Richard F, Desmedt C, Floris G
  • Revue Lab Invest
  • Date de publication 2025-08
Corrigendum to \"Histopathological Insights into Metastatic Breast Cancer Gained From Rapid Autopsies\" [Laboratory Investigation 105(2025) 104202].
  • Late Toxicity and Long-Term Quality of Life in Survivors of Cancer of the Major Salivary Glands More Than 5 Years After Diagnosis: A Multi-National Study.

  • Auteurs Singer S, Amdal CD, Bjordal K, Herlofson BB, Astrup GL, Boehm A, Wöhner U, Hammerlid E, Gama RR, Jacinto AA, Jansen F, de Leeuw IV, Dragan T, Duprez F, Kiyota N, Pinto M, Krüger M, Guntinas-Lichius O, Inhestern J, Tramacere F, Bonomo P, Fanetti G, Nuyts S, Plath M, Stempler N, Westgaard KL, Taylor KJ
  • Revue Head Neck
  • Date de publication 2025-08
Late Toxicity and Long-Term Quality of Life in Survivors of Cancer of the Major Salivary Glands More Than 5 Years After Diagnosis: A Multi-National Study.
  • Safety of having a subsequent pregnancy after prior diagnosis of breast cancer during pregnancy in young BRCA carriers.

  • Auteurs Perachino M, Blondeaux E, Delucchi V, Bernstein Molho R, Frank S, Paluch-Shimon S, Linn S, Di Meglio A, Peccatori F, Moore HCF, Parokonnaya A, Renaud T, Rodriguez Wallberg KA, Partridge AH, Pogoda K, Ferrari A, Wildiers H, Toss A, Rousset-Jablonski C, Kim HJ, Varela M, Cordoba O, Tanase Damian C, Marhold M, Fabi A, Graff SL, Rodriguez-Hernandez A, Okano M, Duchnowska R, Luna Pais H, Di Rocco R, Azim HA, Mariamidze E, Kourie HR, Arecco L, Carrasco E, Agostinetto E, Balmana J, Saura C, Lambertini M
  • Revue ESMO Open
  • Date de publication 2025-08
Safety of having a subsequent pregnancy after prior diagnosis of breast cancer during pregnancy in young BRCA carriers.
  • Breastfeeding after breast cancer in young BRCA carriers.

  • Auteurs Blondeaux E, Delucchi V, Mariamidze E, Bernstein-Molho R, Frank S, Ferrari A, Linn S, Jeong Kim H, Agostinetto E, Paluch-Shimon S, Cortesi L, Di Meglio A, Balmana J, Yerushalmi R, Rodriguez-Wallberg KA, Renaud T, Cui W, Moore HCF, Wong SM, Pogoda K, Lustberg M, Phillips KA, Han S, Puglisi F, Vernieri C, Bajpai J, Sonnenblick A, Rousset-Jablonski C, De Marchis L, De Giorgi U, Bianchini G, Texeira L, Duhoux FP, Villarreal-Garza C, Sini V, Fruscio R, Del Mastro L, Demeestere I, Azim HA, Peccatori FA, Partridge AH, Lambertini M
  • Revue J Natl Cancer Inst
  • Date de publication 2025-07
Breastfeeding after breast cancer in young BRCA carriers.
  • STRONG II trial: stereotactic body radiation therapy following chemotherapy for unresectable perihilar cholangiocarcinoma - a single-arm multicentre phase II study.

  • Auteurs van Loosbroek SY, Milder MTW, de Ruysscher D, Vaes RDW, den Toom W, Willemssen F, Eskens F, Homs MYV, Groot Koerkamp B, van Driel LMJW, Seppenwoolde Y, van Werkhoven E, Intven M, Haj Mohammad N, de Bruijne J, Versteijne E, Bruynzeel AM, Brandts F, Erdmann JI, Westdorp H, Braam PM, Tjwa ETTL, Bouchart C, Demols A, Gulyban A, Buijsen J, de Vos-Geelen J, Dewulf M, Joye I, Vandamme T, Vonghia L, de Groot DJ, Dieters M, Ubbels FJF, Hoogwater FJH, Heijmen B, Méndez Romero A
  • Revue BMJ Open
  • Date de publication 2025-07
STRONG II trial: stereotactic body radiation therapy following chemotherapy for unresectable perihilar cholangiocarcinoma - a single-arm multicentre phase II study.
Erasme hospital

Hôpital Erasme

Consultez toutes les publications scientifiques d'Erasme

Huderf hospital

Hôpital pédiatrique Reine Fabiola

Consultez toutes les publications scientifiques de l'Hôpital pédiatrique Reine Fabiola

Decorative image of doctor and patient

Toutes les publications scientifiques du H.U.B.

Consulter toutes les publications scientifiques du H.U.B.